Business Description
LTR Pharma Ltd
ISIN : AU0000305294
Description
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.98 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 77.68 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -67.7 | |||||
3-Year EPS without NRI Growth Rate | -67.7 | |||||
3-Year FCF Growth Rate | -89 | |||||
3-Year Book Growth Rate | 137.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 31.75 | |||||
9-Day RSI | 40.28 | |||||
14-Day RSI | 45.68 | |||||
3-1 Month Momentum % | 35 | |||||
6-1 Month Momentum % | -9.24 | |||||
12-1 Month Momentum % | 86.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 57.44 | |||||
Quick Ratio | 57.4 | |||||
Cash Ratio | 56.29 | |||||
Days Sales Outstanding | 853.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.1 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -6852.87 | |||||
Net Margin % | -5700.64 | |||||
EBITDA Margin % | -5655.41 | |||||
FCF Margin % | -4435.67 | |||||
OCF Margin % | -4432.48 | |||||
ROE % | -28.97 | |||||
ROA % | -28.48 | |||||
ROIC % | -1260.33 | |||||
3-Year ROIIC % | -1495.36 | |||||
ROC (Joel Greenblatt) % | -10210.34 | |||||
ROCE % | -28.76 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 490 | |||||
PB Ratio | 3.31 | |||||
Price-to-Tangible-Book | 3.27 | |||||
EV-to-EBIT | -7.32 | |||||
EV-to-EBITDA | -7.33 | |||||
EV-to-Revenue | 414.28 | |||||
EV-to-FCF | -9.34 | |||||
| Price-to-Net-Current-Asset-Value | 3.5 | |||||
| Price-to-Net-Cash | 3.5 | |||||
Earnings Yield (Greenblatt) % | -13.66 | |||||
FCF Yield % | -7.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LTR Pharma Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.157 | ||
| EPS (TTM) (A$) | -0.05 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 96.92 | ||
| 14-Day RSI | 45.68 | ||
| 14-Day ATR (A$) | 0.03981 | ||
| 20-Day SMA (A$) | 0.55275 | ||
| 12-1 Month Momentum % | 86.21 | ||
| 52-Week Range (A$) | 0.29 - 0.81 | ||
| Shares Outstanding (Mil) | 181.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LTR Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LTR Pharma Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
LTR Pharma Ltd Frequently Asked Questions
What is LTR Pharma Ltd(ASX:LTP)'s stock price today?
The current price of ASX:LTP is A$0.49. The 52 week high of ASX:LTP is A$0.81 and 52 week low is A$0.29.
When is next earnings date of LTR Pharma Ltd(ASX:LTP)?
The next earnings date of LTR Pharma Ltd(ASX:LTP) is .
Does LTR Pharma Ltd(ASX:LTP) pay dividends? If so, how much?
LTR Pharma Ltd(ASX:LTP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on LTR Pharma Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers